Agoracom Blog Home

Posts Tagged ‘CSE’

Harborside Inc. $HBOR.ca $HBORF Announces Upcoming Conference Participation $VFF.ca $HARV.ca $ACB.ca

Posted by AGORACOM at 8:58 AM on Monday, April 12th, 2021
This image has an empty alt attribute; its file name is HBOR-square.jpg
  • Going Deep Intro the California Cannabis Market Conference
  • Presenting Wednesday, April 14, 2021, 12:50

Harborside Inc. (“Harborside” or the “Company”) (CSE: HBOR),(OTCQX: HBORF) a California-focused, vertically integrated cannabis enterprise, today announced Matt Hawkins, Chairman of the Board, and Peter Bilodeau, Interim CEO, will participate in the upcoming PI Financial Golden State Green: Going Deep Intro the California Cannabis Market Conference on Wednesday, April 14, 2021. Management is scheduled to present a Company overview at 12:50 p.m. ET. To register for the event, click here.

About Harborside:
Harborside Inc. is one of the oldest and most respected cannabis retailers in California, operating three of the major dispensaries in the San Francisco Bay Area, a dispensary in the Palm Springs area outfitted with Southern California’s only cannabis drive-thru window, a dispensary in Oregon and a cultivation/production facility in Salinas, California. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of California consumers. In 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States and today holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. Harborside is currently a publicly listed company on the Canadian Securities Exchange (“CSE”) trading under the ticker symbol “HBOR”. Additional information regarding Harborside is available under Harborside’s SEDAR profile at www.sedar.com.

PlantX $VEGA $PLTXF Announces Monthly Gross Revenues of $1,565,982 for March 2021 and $1,353,613 for February 2021 $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 8:41 AM on Monday, April 12th, 2021
  • Announced that it achieved record monthly gross revenue of $1,565,982 for March 2021 and a revenue of $1,353,613 for February 2021
  • Cost of Goods Sold were $1,152,276 and $994,260 for March and February, respectively.

VANCOUVER, BC , April 12, 2021 – PlantX Life Inc. (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF) (“PlantX” or the “Company”) is pleased to announce that it achieved record monthly gross revenue of $1,565,982 for March 2021 and a revenue of $1,353,613 for February 2021 . Cost of Goods Sold were $1,152,276 and $994,260 for March and February, respectively.

PlantX continues to experience month-over-month revenue increases, as shown by the financial results in recent months. For the month of March 2021 , the Company achieved a new record gross revenue of $1,565,982 , reflecting a 15.6% increase from February 2021 and a 43.7% increase from January 2021 . These accomplishments are a reflection of the Company’s dynamic expansion and its unwavering commitment to delivering the best quality products and services to its loyal customer base. The monthly revenue increase also builds confidence in PlantX’s capabilities to continue on a growth trajectory for the rest of 2021.

“The Company’s progress is a manifestation of its results-driven strategy to capitalize on high-growth verticals, create strategic partnerships and expand globally,” said PlantX CEO, Julia Frank . “PlantX continues to add value as a leader in the plant-based industry.”

“The recent revenue growth is a strong indicator that we are consistently building great momentum in our quest to thrive as a business,” said PlantX Founder, Sean Dollinger . “Our financial progress continues to accelerate month after month, and we have no intention of slowing down.”

The financial results disclosed in this press release are management prepared and have not been audited or reviewed by the Company’s auditors. Unless otherwise indicated, all amounts are expressed in Canadian dollars.

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of likeminded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life.

The Company website is http://investor.PlantX.com/ .

To visit the Company’s YouTube channel , click here .

You can tune in to PlantX’s live vodcast tonight at 8PM EST to watch a discussion between the PlantX Founder and the and PlantX CFO. To view the show, click here .

Read More: https://agoracom.com/ir/PlantX/forums/discussion/topics/758869-plantx-announces-monthly-gross-revenues-of-1-565-982-for-march-2021-and-1-353-613-for-february-2021/messages/2311569#message

Globally Acclaimed Pediatrics Nutrition and Allergies Experts Join Else’s $BABY.ca $BABYF Advisory Board $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 8:31 AM on Monday, April 12th, 2021
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Prof. Hania Szajewska will lead the Company’s clinical studies in Europe . Dr. Carina Venter will lead key studies in the U.S.

VANCOUVER, BC , April 12, 2021 ELSE NUTRITION HOLDINGS INC. (TSXV: BABY ) (OTCQX: BABYF ) (FSE: 0YL ) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company , is pleased to announce the addition of 2 world-class experts to its Scientific Advisory Board.

“The importance of these 2 new Advisory Board members cannot be understated. Prof. Szajewska and Dr. Venter bring immense and invaluable expertise which significantly bolsters our pathway toward commercializing clean label, plant-based infant nutrition in both the U.S. and European markets,” said Hamutal Yitzhak , Else CEO & Co-Founder.

Professor Hania Szajewska , MD, is Professor and Chair of the Department of Pediatrics at the Medical University of Warsaw . Until June 2019 , she served as the Editor-in-Chief of the Journal of Pediatric Gastroenterology and Nutrition . Previously, Prof. Szajewska served as a member of the Council and then as the General Secretary of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). She also served as the Secretary of the ESPGHAN Committee on Nutrition. Most recently ( January 2019 ), she joined the Board of Directors of the International Scientific Association for Probiotics and Prebiotics. She has co-authored more than 320 publications. In 2020, Prof. Szajewska has been ranked as one of the world’s top 2% most-cited researchers. She will lead Else’s clinical studies in Europe .

Dr. Carina Venter obtained her PhD from the University of Southampton. She moved from the UK in 2015 where she had been performing research into food allergies and allergy prevention as a Senior Lecturer at the University of Portsmouth at the David Hide Centre on the Isle of Wight. Dr. Venter (PhD RD) is currently an Associate Professor of Pediatrics, Section of Allergy/Immunology at the Children’s Hospital Colorado and University of Colorado Denver , where she is conducting research in allergy prevention and working with children with food allergies.  She is a member of American, European, and British Allergy Societies.  She is a member of European and American food allergy guidelines on Allergy Prevention. She was also a member of the NICE (UK) and National Institutes for Allergy and Infectious Diseases Food Allergy guidelines. She will lead Else’s hypoallergenicity studies in the U.S.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board  members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies,  and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .

Read More: https://agoracom.com/ir/ElseNutritionHoldings/forums/discussion/topics/758858-globally-acclaimed-pediatrics-nutrition-and-allergies-experts-join-else-s-advisory-board/messages/2311556#message

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 9:28 AM on Saturday, April 10th, 2021

A weekly summary of Novamind news and media

MULTIMEDIA April 8, 2021

Yaron Conforti on Psychedelic Medicine Today and 10 Years from Now

Novamind’s CEO talks with PsyFi about the future of healthcare and the spectrum of alternative services available today in our clinics.

MULTIMEDIA April 8, 2021

Dr. Reid Robison on How Psychedelic Healing Works and Who Benefits From It

Novamind’s CMO talks with Mark Novak about the potential long-term effects of using psychedelics in a therapeutic setting.

INDUSTRY NEWS April 7, 2021

Bringing New Hope to a State Struggling with Mental Illness

The Daily Utah Chronicle speaks with Novamind’s CMO, Dr. Reid Robison, on the game-changing effects of psychedelic-assisted therapy.

View all media

Could Group Therapy Get A Boost From Psychedelics?

A new psychedelic group therapy trial is set to take place this fall with six veterans who suffer from post-traumatic stress disorder. It’s another example of how researchers are investigating psychedelic-assisted group therapy to help patients connect more deeply and broaden access to the potential medical benefits of psychedelics.

UW-Madison Pioneers Master’s Program in Psychoactive Drugs

The University of Wisconsin–Madison School of Pharmacy is launching a new master’s program on Psychoactive Pharmaceutical Investigation. As the first graduate level, degree-based training program for the study and applications of psychedelics, it marks a significant step toward a more global understanding of these groundbreaking therapies, and a highly trained workforce to administer them.

Follow @novamind_inc on Instagram

 
 

For further information, contact:

Bill Mitoulas
Investor Relations
Telephone: +1 (416) 479 9547
Email: [email protected]

KWESST $KWE.ca $KWEMF Announces Upsizing of Previously Announced Brokered Private Placement $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 8:37 AM on Friday, April 9th, 2021

  • Announce that in connection with its previously announced brokered private placement (the “Offering“), the Company and PI Financial Corp., the lead agent and sole bookrunner (the “Lead Agent“) for the Offering, have agreed to increase the size of the Offering to raise total gross proceeds of $4 million.
  • The Company now intends to issue 3,200,000 units of the Company (the “Units“) at a price of C$1.25 per Unit.
  • The 3,200,000 Units have been allocated to subscribers and the Offering is scheduled to close on or about April 29, 2021, or such date as agreed upon between the Company and the Lead Agent.
  • Given the upsize to the Offering, the parties have agreed to remove the previously announced over-allotment option.

Ottawa, Ontario–(April 9, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (“KWESST” or “the Company”) is pleased to announce that in connection with its previously announced brokered private placement (the “Offering“), the Company and PI Financial Corp., the lead agent and sole bookrunner (the “Lead Agent“) for the Offering, have agreed to increase the size of the Offering to raise total gross proceeds of $4 million. The Company now intends to issue 3,200,000 units of the Company (the “Units“) at a price of C$1.25 per Unit. The 3,200,000 Units have been allocated to subscribers and the Offering is scheduled to close on or about April 29, 2021, or such date as agreed upon between the Company and the Lead Agent. Given the upsize to the Offering, the parties have agreed to remove the previously announced over-allotment option.

“The KWESST Offering was very well received by investors and resulted in significant demand for our financing, which led to the increase in size announced today. The proceeds will be used to accelerate our go-to market initiatives of KWESST’s various products,” said Jeffrey MacLeod, KWESST’s President and CEO. “One of our priorities is to finalize the acquisition of the Low Energy Cartridge (“LEC”) non-lethal system, which is expected to close concurrently with the Offering, after which we will begin the commercialization of this product. The Company has an accelerated plan to roll out the LEC product in response to market interest and high growth across all segments of the non-lethal market where a strong preference is being expressed for a safer, cartridge-based system over traditional systems such as Taser, beanbag shotgun shells and rubber bullets that can and do result in fatalities.”

Other corporate priorities to be funded with the proceeds from the Offering include the productization of the GreyGhost micro-drone missile, ramping up the Company’s ATAK Centre of Excellence business, and accelerating the productization of the Phantom electronic decoy.

Each Unit will be comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (“Warrant“). Each Warrant shall be exercisable to acquire one Common Share (a “Warrant Share“) at a price of C$1.75 per Warrant Share for a period of 24 months from the closing of the Offering. If at any time after four (4) months and one (1) day following the Closing Date, the trading price of the Shares on the TSX Venture Exchange is equal to or exceeds $3 for a period of 10 consecutive trading days, as evidenced by the price at the close of market, the Company shall be entitled to notify the holders of Warrants of its intention to force the exercise of the Warrants. Upon receipt of such notice, the holders of Warrants shall have 30 days to exercise the Warrants, failing which the Warrants will automatically expire.

The securities to be issued under the Offering will be offered by way of private placement in each of the provinces of Canada and such other jurisdictions as may be determined by the Company, in each case, pursuant to applicable exemptions from the prospectus requirements under applicable securities laws.

The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals including the approval of the Exchange. It is not a requirement for the closing of the Offering that the Company issues the entire 3,200,000 Units referenced above. The Units to be issued under the Offering will have a hold period of four months and one day from Closing.

The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.

Read More: https://agoracom.com/ir/Kwesst/forums/discussion/topics/758779-kwesst-announces-upsizing-of-previously-announced-brokered-private-placement/messages/2311369#message

ImagineAR $IP.ca $IPNFF Selected by 2 Motor Sports Organizations on Second Hype Sports Innovation Draft Day $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Posted by AGORACOM-JC at 8:18 AM on Friday, April 9th, 2021

ImagineAR Now Selected by a Total of 15 Major Sports Organizations During 2021 Hype Sports Innovation Accelerator

  • Announced two Motor Sports Organizations selected ImagineAR during the Hype Sports Innovation Second Draft Day on April 8, 2021 .
  • HYPE Sports Innovation has built the largest global ecosystem in sports innovation.
  • With over 40,000 members, including retail brands, athletic clubs, federations and academia together with over 11,000 startups, HYPE has an unrivalled capacity for outreach to global partners across all sectors in this highly diverse field.

VANCOUVER, BC and ERIE, Pa. , April 9, 2021 – Imagine AR Inc. (CSE: IP) (OTCQB: IPNFF) (“ImagineAR” or “Company”) an Augmented Reality Company that enables sports teams, businesses and enterprises to instantly create their own AR mobile campaigns, is pleased to announce  two Motor Sports Organizations selected ImagineAR during the Hype Sports Innovation Second Draft Day on April 8, 2021 .

New Motor Sports Draft Selections:

Automotive Industries 40,000 audited magazine recipients plus AI`s online readership viewing 1.86m pages per month are the who`s who of automotive decision-making, including major carmakers, system suppliers, 1st tier and major 2nd tier award winning supplier companies.

AirSpeeder is a proposed motorsport series for electric flying vehicles. The teams may be provided racing electric quadcopters, known as ‘Speeders’ that can fly at speeds of up to 200km/h by Alauda.

Previous Selection List:

NFL: Minnesota Vikings

MLB: Philadelphia Phillies

NHL: St. Louis Blues , Vegas Golden Knights

World Governing Body of Cricket: International Cricket Council (ICC)

World Governing Body of Football: Deutscher Fußball-Bund (DFB)

Bundesliga: 1. FC Koln

Leading provider of Local Sports & News ( USA ): Sinclair Broadcast Group

Leading provider Mass Media & Sports Properties ( Canada ): Rogers Sports & Media

Serie A (Top flight of Italian Football): Bologna FC

Uruguayan Primera Division: C.N.deF.

MLS & USL: Inter Miami

Categoria Primera A: Atletico Nacional

HYPE Sports Innovation has built the largest global ecosystem in sports innovation. With over 40,000 members, including retail brands, athletic clubs, federations and academia together with over 11,000 startups, HYPE has an unrivalled capacity for outreach to global partners across all sectors in this highly diverse field.

Source: https://agoracom.com/ir/Imaginear/forums/discussion/topics/758777-imaginear-selected-by-2-motor-sports-organizations-on-second-hype-sports-innovation-draft-day/messages/2311367#message

AGORACOM Small Cap 60: ImagineAR $IP.ca $IPNFF Concludes “March Madness” With 13 Announcements / 23 Deals $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Posted by AGORACOM-JC at 3:50 PM on Thursday, April 8th, 2021

PK Beans $BEAN Enters into a Shares Purchase Agreement with Children’s Health Food Company. From Sustainable Clothing to Healthy Snacks, PK Beans to be a True Children’s Wellness Brand $LULU

Posted by AGORACOM-JC at 9:15 AM on Thursday, April 8th, 2021
  • Entered into a share purchase agreement with certain vendors pursuant to which the Company has agreed to acquire 100% of the common shares of Les Petits Terribles Inc.
  • Acquisition complements its high-quality children’s clothing line, and marks a powerful brand expansion as a leader in total children’s wellness.

Vancouver, British Columbia–(April 8, 2021) –  Peekaboo Beans Inc. (CSE: BEAN) (OTC Pink: PBBSF) (“PK Beans” or the “Company”) has entered into a share purchase agreement with certain vendors (the “Vendors“) pursuant to which the Company has agreed to acquire 100% of the common shares of Les Petits Terribles Inc. (the “LPTI Shares“) from the Vendors (the “Transaction“) and launches Private Placement of Convertible Debenture Units.

For PK Beans, the acquisition complements its high-quality children’s clothing line, and marks a powerful brand expansion as a leader in total children’s wellness.

“Healthy, on-the-go snacks and meals are what millennial parents are choosing” states Traci Costa, PK Beans Founder and CEO. “The industry is skyrocketing. Add to that, our sustainable, high-quality clothing and we become the go-to brand in children’s wellness. We believe what kids put into their bodies is as important as what they put on their bodies“.

Led by Chef Benjamin Gagné, LPTI specializes in healthy snacks and easy quick meals for children.

“Our high-protein, wholefood recipes have no added sugar, salt or artificial ingredients. They satisfy parents who want healthy options without compromising taste and convenience”, adds Gagné.

In consideration for the LPTI Shares, the Company has agreed to issue to, or as directed by the Vendors 4,000,000 common shares in the capital of the Company (the “Common Shares“) at an issue price of $0.075 per Common Share.

Completion of the Transaction remains subject to completion of normal closing conditions for a transaction of this nature, including delivery of all closing documents representing the transfer of the LPTI Shares to the Company and related documents. LPTI is the holder of intellectual property rights related to children’s food products, which the Company hopes to utilize as part of an expansion into a new industry segment with children’s lifestyle products, to complement its children’s clothing business.

In connection with the Transaction the Company further announces that it is launching a non-brokered private placement of convertible debenture units (each, a “CD Unit” and collectively, the “CD Units“) to the Vendors for aggregate gross proceeds of up to $110,000 (the “Offering“). The net proceeds of the Offering will be used for general working capital.

Each CD Unit will be offered at a price of $1,000 and will be comprised of one unsecured convertible debenture with a principal amount of $1,000 (each, a “Debenture” and collectively, the “Debentures“) and 5,000 common share purchase warrants of the Company (each, a “Warrant” and collectively, the “Warrants“). Each Warrant will entitle the holder thereof to acquire one Common Share at a price of $0.15 per share for a period of two years from the closing date of the Offering (the “Closing Date“).

The Debentures will mature and be repayable on the date that is two years from the Closing Date (the “Maturity Date“) and bear interest at a rate of 12% per annum until maturity, which will be calculated and payable semi-annually on the last day of June and December in each year. The principal amount of the Debentures and any accrued and unpaid interest will be convertible into Common Shares at a conversion price of $0.10 (the “Conversion Price“). The terms of the Debentures further provide that the Company may from time to time, at the Company’s option, prepay all or part of the principal amount plus accrued and unpaid interest without penalty or bonus.

All securities issued in connection with the Offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described in this news release in the United States. Such securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws, and, accordingly, may not be offered or sold within the United States, or to or for the account or benefit of persons in the United States or “U.S. Persons”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

Read More: https://agoracom.com/ir/PKBeans/forums/discussion/topics/758712-pk-beans-enters-into-a-shares-purchase-agreement-with-children-s-health-food-company-from-sustainable-clothing-to-healthy-snacks-pk-beans-to-be/messages/2311222#message

KWESST $KWE.ca $KWEMF Releases Video and Photos Of TASCS IFM For 81 mm Mortar in U.S. Military Exercises $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 8:25 AM on Thursday, April 8th, 2021
  • Release approved footage and pictures of the KWESST TASCS Integrated Fires Module (“IFM”) in action in live-fire exercises at a U.S. military base.
  • These exercises are being held pursuant to a contract with a key U.S. military customer
  • Video and photos depict the TASCS IFM system fitted on the 81 mm mortar and firing at a range of 2,600 metres.

Ottawa, Ontario–(April 8, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (“KWESST” or “the Company”) is pleased to release approved footage and pictures of the KWESST TASCS Integrated Fires Module (“IFM”) in action in live-fire exercises at a U.S. military base. These exercises are being held pursuant to a contract with a key U.S. military customer (for further information please see the December 2020 news release at https://kwesst.com/news/kwesst-announces-c1-1-million-follow-on-order-for-tascs-ifm-from-key-u-s-military-customer-2/ ) which is currently being delivered.



Cannot view this video? Visit:
https://www.youtube.com/watch?v=K4oOEczVOkM

The pictures are available at: https://kwesst.com/systems/tascs-ifm/

The video and photos depict the TASCS IFM system fitted on the 81 mm mortar and firing at a range of 2,600 metres. With TASCS IFM, the mortar team is able to acquire targets in 15 seconds compared to the traditional 15 minutes, and engage targets with unprecedented accuracy. The 81mm mortar is just one of many firing platforms that can be fitted with the TASCS IFM systems and requires no modification of the firing platform or ammunition. It effectively turns a traditional “dumb” firing platform into a “smart” weapons system by providing soldiers on the ground with real-time networked situational awareness and precision targeting information.

About KWESST

KWESST develops and commercializes high-value ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defence and security industries. The company’s current portfolio of unique proprietary offerings include: its signature TASCSTM (Tactical Awareness and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users’ smart devices and weapons; the autonomous GreyGhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact; a Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel; and, the PhantomTM electronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries. All systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems including Frontline, Edge, Killswitch and ATAK (Android Tactical Assault Kit) among others. KWESST also has developmental “smart ordnance” projects including its “Shot Counter” system, which records the number and type of rounds fired, for optimized firearms maintenance and performance. The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE. KWESST trades on the TSX Venture Exchange under the symbol KWE and on the U.S. OTCQB under the symbol KWEMF.

Read More: https://agoracom.com/ir/Kwesst/forums/discussion/topics/758710-kwesst-releases-video-and-photos-of-tascs-ifm-for-81-mm-mortar-in-u-s-military-exercises/messages/2311218#message

Empower Clinics $CBDT.ca $EPWCF Partners with Leading U.S. Digital Marketing Agency to Launch Direct-to-Consumer e-Commerce Solutions $DMTK $LMD.ca $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-JC at 8:19 AM on Thursday, April 8th, 2021

Snow Agency recognized as #1 U.S. digital marketing agency

  • Announced a partnership with Snow Agency to launch its direct-to-consumer (DTC) e-commerce solutions.
  • Snow Agency is a performance digital marketing and creative agency whose customized brand strategies and content production maximize the impact of direct response ads and creatives on Facebook/Instagram, Google/YouTube, Snapchat, and Email/SMS
  • Collaboration will allow Empower patients, existing and prospective, to benefit from an accessible, seamless and educative experience when purchasing at-home diagnostics test kits

VANCOUVER BC / April 8, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens – today announced a partnership with Snow Agency to launch its direct-to-consumer (DTC) e-commerce solutions.

The Snow Agency is a performance digital marketing and creative agency whose customized brand strategies and content production maximize the impact of direct response ads and creatives on Facebook/Instagram, Google/YouTube, Snapchat, and Email/SMS. To date, they’ve brought in more than $250 million USD in sales for their clients. The Snow Agency has been recognized on Yahoo! Finance ranked as the #1 US Digital Marketing Agency & Digital Agency in January 2021 by Design Rush, a top B2B marketplace connecting brands with agencies.

The collaboration will allow Empower patients, existing and prospective, to benefit from an accessible, seamless and educative experience when purchasing at-home diagnostics test kits. Today patients can purchase at-home COVID-19 saliva test kits by phone or email at www.kaitests.com.

“Empower is committed to make our solutions as convenient as possible to all patients in North America. A DTC e-commerce solution is a key part of that solution.” said Steven McAuley, Chairman & CEO of Empower. “I am privileged to now count Snow Agency as a partner in our journey to deliver at-home testing solutions and empower patients to take control of their own health data. Even with vaccines, ongoing testing is desperately needed because more testing, along with mask-wearing and physical distancing, will get people back into offices, planes and classrooms and help catch cases that go undetected”.

“This partnership is really making a positive difference in people’s lives. We know that we can reach millions of consumers with success for brands. We see our partnership with Empower as our contribution from Snow Agency to help reopen the economy, allow people to travel with confidence and getting back to normal life.” said Dan Snow, CEO and Co-founder of Snow Agency.

“As a trained physician and a digital marketing entrepreneur, I fully believe in Empower’s at-home diagnostic testing solutions especially its integrated laboratory services at Kai Medical. It’s the time now to digitally transform healthcare, focus on accessibility and convenience for patients and save valuable time and money on stretched public health services. People will need to get tested regularly so we can all get back to normal” said Dr. Jonathan Snow, COO and Co-founder of Snow Agency.

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

ABOUT EMPOWER:

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors:
Steven McAuley CEO
[email protected]
604-789-2146

Investors:
Tamara Mason
Business Development & Communications
[email protected]
416-671-5617

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the acquisition of Kai Medical Laboratory; the transaction terms; the expected number of clinics and patients following the closing; the future potential success of Kai Medical Laboratory, Sun Valley’s franchise model; launch of new healthcare centers and the occurrence thereof; that the Company can bring healthcare to millions of Canadians; that new healthcare services can be added and that the Company will be positioned to be a market- leading service provider for complex patient requirements in 2020 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that Kai Medical Laboratory will successfully win any US Government RFP; that the MedX Health pilot program will be successful; that Empower will place the MedX Health teledermatology product in health centers in North America; that the Company’s products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for Canadian clinics or Kai Medical Laboratory expansion inn 2Q 2021; that general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.